Company / Current Liabilities
Eloxx Pharmaceuticals, Inc. Current Liabilities History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$22.7M
FY2025
5-year range
$369.0K / $22.7M
FY2021-FY2025
Trend
+6051.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities changed +6051% YoY in FY2025, a notable deviation from the 3-year average annual change of +1980%.
Based on SEC 10-K filings.
$23M in FY2025 with a 10-year CAGR of +40.1%.
Increased from $778,516 to $23M over the past 10 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +40.1%
Key checks
Key Insights
- In FY2025, current liabilities increased 6051.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.7M | +6051.1% |
| FY2016 | $369.0K | -52.6% |
| FY2015 | $778.5K | -57.3% |
| FY2014 | $1.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026